XM does not provide services to residents of the United States of America.
C
C

Cognizant

News

India's HCLTech a 'sell' but preferred over IT leaders Infosys, TCS, says Ambit Capital

BUZZ-India's HCLTech a 'sell' but preferred over IT leaders Infosys, TCS, says Ambit Capital ** HCLTech HCLT.NS hits record high on Q2 beat-and-raise report before paring gains to 0.1%; IT index .NIFTYIT flat ** Guidance hike and deal flow declines "do not enthuse on a sharp recovery"; growth should stay below pre-Covid levels, says Ashwin Mehta, h
C
I

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change MongoDB Inc MDB.OQ +6.6% CrowdStrike Holdings Inc CRWD.OQ +5.3% Zscaler Inc ZS.OQ +5.2% Micron Technology Inc MU.OQ +4.0% Atlassian Corp TEAM.OQ +3.6% Bottom Performers Percent Change Advanced Micro Devices Inc AMD.OQ -4.7% Moderna Inc MRNA.OQ -3.6% Verisk Analytics Inc VRSK.OQ -3.5% Cognizant Technology Solutions Corp CTSH.OQ -3.0% Warner Bros Discovery Inc WBD.OQ -2.9% The Nasda
C
M
V
A
U
A
C

Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change MongoDB Inc MDB.OQ +5.5% CrowdStrike Holdings Inc CRWD.OQ +4.5% Micron Technology Inc MU.OQ +4.2% Zscaler Inc ZS.OQ +4.0% Atlassian Corp TEAM.OQ +3.9% Bottom Performers Percent Change PayPal Holdings Inc PYPL.OQ -3.3% Verisk Analytics Inc VRSK.OQ -3.2% Cognizant Technology Solutions Corp CTSH.OQ -2.9% Moderna Inc MRNA.OQ -2.2% Warner Bros Discovery Inc WBD.OQ -2.0% The Nasdaq 100
C
M
P
V
U
A
C

UnitedHealth tech unit's rivals say new, post-hack customers are staying

FOCUS-UnitedHealth tech unit's rivals say new, post-hack customers are staying By Leroy Leo and Sriparna Roy Sept 19 (Reuters) - Smaller rivals to UnitedHealth's UNH.N tech unit Change Healthcare say they are signing longer-term contracts with hospitals and other customers who had temporarily switched from the company after February's cyberattack shut down the unit's services.
C

Oracle shares pare gains as analysts weigh over $100 billion fiscal 2029 revenue forecast

UPDATE 1-Oracle shares pare gains as analysts weigh over $100 billion fiscal 2029 revenue forecast Shares rise 1.9% Oracle forecasts FY29 revenue to be $104 billion Raises fiscal 2026 revenue outlook Adds analyst comment in paragraphs 3 and 4, updates shares By Jaspreet Singh Sept 13 (Reuters) - Oracle ORCL.N shares pared most of their gains on Friday after spiking nearly 8%, with some analysts expressing reservations about the company's forecast of crossing $100 billion in revenue in fiscal 202
A
A
C
M
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.